# E-DRUG: Re: Drug Information for Patients **URL:** \ **Category:** e-drug\ **Created:** [June 8, 1999, 6:02pm UTC](https://talk.edrugplus.org/t/e-drug-re-drug-information-for-patients/5239 "1999-06-08T18:02:15Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![edp](https://avatars.discourse-cdn.com/v4/letter/e/ea5d25/32.png) [@edp](https://talk.edrugplus.org/u/edp)\ **Post date:** [June 8, 1999, 6:02pm UTC](https://talk.edrugplus.org/t/e-drug-re-drug-information-for-patients/5239/1 "1999-06-08T18:02:15Z")
E-drug: Re: Drug Information for Patients ---------------------------------------------------------- Dear E-Druggers Dr Ekbal drew attention to the influence of the British National Formulary in the formulation of the Kerala State Formulary. It would be interesting to know of other formularies that have been similarly modelled on the BNF - although the Essential Drugs Project no longer operates a BNF distribution scheme, we used to receive many requests for it from formulary committees throughout the world. We would be glad to receive feedback and let e-drug and the BNF editorial office know the results. Regarding 'Banned and Bannable Drugs', in a very different context the Public Citizen Health Research Group's 'Worst Pills, Best Pills' has, I believe, had a similar success. Philippa Saunders Philippa Saunders & Gill Stoker Essential Drugs Project 77 Lee Road Blackheath London SE3 9EN UK tel/fax 44 (0)20 8318 1419 email edp@gn.apc.org -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.